the Journal of Medicinal Chemistry
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Why doesn't coffee taste like caffeine?
Why doesn't coffee taste like caffeine? Stephanie Baum Scientific Editor Robert Egan Associate Editor Though decaf fans might disagree, caffeine is a critical component of a cup of joe. This compound is incredibly bitter on its own, but regular coffee itself is not.
Do turmeric and curcumin have any actual health benefits?
As the temperature drops in Australia, I’ve been seeing recipes on social media for “golden milk”, a mix of turmeric, other spices and honey in warm milk. In addition to being delicious, it is meant to have medicinal qualities, thanks to a compound in turmeric called curcumin, which gives it its distinct yellow colour. Curcumin is said to have anti-inflammatory properties that are protective against cancer, arthritis, hay fever, Alzheimer’s disease, menopause symptoms and many other ailments.
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy. Wainberg, co-director of UCLA Health’s GI Oncology Program, was leading a clinical trial of a new drug called daraxonrasib. All the study participants previously had chemotherapy that was starting to fail.
Some drugs 'fail' because of unrealistic testing conditions, scientists discover
Some drugs 'fail' because of unrealistic testing conditions, scientists discover Sadie Harley Scientific Editor Robert Egan Associate Editor A drug once dismissed as ineffective suddenly worked—when scientists tested it under more realistic conditions that mimic the human body. In this surprising new discovery, Northwestern University scientists uncovered a hidden rule of drug behavior. A medicine's effectiveness can change dramatically depending on the conditions inside our cells.
Sweet basil carbon dots show potential for sustainable agriculture
June 6, 2026 dialog Sweet basil carbon dots show potential for sustainable agriculture Sadie Harley Scientific Editor Robert Egan Associate Editor What if a common herb found in the kitchen could help farmers grow healthier crops? As the global population grows and agriculture faces increasing environmental challenges, scientists are searching for innovative ways to improve crop productivity while reducing reliance on chemical inputs. Nanotechnology has emerged as a potential solution.
Novel synthetic biomolecule degrades disease-related proteins
Novel synthetic biomolecule degrades disease-related proteins Lisa Lock Scientific Editor Robert Egan Associate Editor Northwestern Medicine scientists have developed a novel synthetic biomolecular condensate that can degrade intracellular disease-causing proteins, providing a framework for new therapeutic approaches for a wide range of diseases, as detailed in a recent study published in Nature Communications. Shana Kelley, Ph.D., the Neena B. Schwartz Professor of Chemistry, Biomedical...
Scientists got mouse eyes to perform photosynthesis — and no, they didn't turn green
Scientists got mouse eyes to perform photosynthesis — and no, they didn't turn green Special eye drops containing photosynthetic machinery from spinach leaves have helped combat dry eye, a new mouse experiment reveals. Scientists have developed new eye drops that allow mouse eyes to perform certain steps of photosynthesis. The drops, which contain photosynthetic machinery extracted from spinach leaves, use light-driven reactions to improve symptoms of dry eye disease, according to a study...
Fast-moving droplets synthesize key drug compounds at room temperature, no catalysts needed
Fast-moving droplets synthesize key drug compounds at room temperature, no catalysts needed Lisa Lock Scientific Editor Robert Egan Associate Editor Chemical reactions are the backbone to nearly all biological processes, including those used to make new medicines. However, these reactions can often take considerable time and require harsh conditions or materials—potentially inhibiting the timely development of life-changing drugs. Purdue University researcher Graham Cooks and his team at...
How I use AI to turn failed drugs into new medicines
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer).
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
Abstract Nuclear receptors are central regulators of metabolism1, yet therapeutic strategies that enforce continuous receptor activation frequently lead to reduced efficacy and unacceptable toxicity. Here we report a first-principles drug design strategy that aligns pharmacokinetics with physiological signalling cycles. We developed linafexor, a potent non-bile-acid agonist of the farnesoid X receptor (FXR)2; it is engineered for rapid systemic clearance, which enables pulsatile receptor...